Literature DB >> 1551973

Revision of standards for adjusting the cation content of Mueller-Hinton broth for testing susceptibility of Pseudomonas aeruginosa to aminoglycosides.

A L Barry1, L B Reller, G H Miller, J A Washington, F D Schoenknect, L R Peterson, R S Hare, C Knapp.   

Abstract

A multilaboratory study was undertaken to reassess the amount of calcium and magnesium that should be added to Mueller-Hinton broth when testing Pseudomonas aeruginosa against amikacin, gentamicin, isepamicin, netilmicin, and tobramycin. To achieve parity with agar dilution tests, cation-adjusted broth should contain 20 to 25 mg of calcium and 10 to 12.5 mg of magnesium per liter rather than the 50- and 25-mg/liter supplements recommended previously. For quality control of tests with contemporary media, MIC control limits should be adjusted by lowering the current MIC limits by at least 1 doubling-dilution interval.

Entities:  

Mesh：

Substances：

Year:  1992        PMID： 1551973      PMCID： PMC265114          DOI： 10.1128/jcm.30.3.585-589.1992

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN： 0095-1137            Impact factor:   5.948


  7 in total

1.  Selection of a reference lot of Mueller-Hinton agar.

Authors:  H M Pollock; A L Barry; T L Gavan; P C Fuchs; S Hansen; C L Thornsberry; H Frankel; S B Forsythe
Journal:  J Clin Microbiol       Date:  1986-07       Impact factor: 5.948

2.  Antibiotic susceptibility testing of Pseudomonas aeruginosa: selection of a control strain and criteria for magnesium and calcium content in media.

Authors:  L B Reller; F D Schoenknecht; M A Kenny; J C Sherris
Journal:  J Infect Dis       Date:  1974-11       Impact factor: 5.226

3.  Activity of aminoglycoside antibiotics aganst Pseudomonas aeruginosa: specificity and site of calcium and magnesium antagonism.

Authors:  V M Zimelis; G G Jackson
Journal:  J Infect Dis       Date:  1973-06       Impact factor: 5.226

4.  Netilmicin disk susceptibility tests: effect of cations on the MIC correlates.

Authors:  A L Barry; G H Miller; R S Hare; C Thornsberry; R N Jones
Journal:  Eur J Clin Microbiol       Date:  1987-08       Impact factor: 3.267

5.  Cation components of Mueller-Hinton agar affecting testing of Pseudomonas aeruginosa susceptibility to gentamicin.

Authors:  M A Kenny; H M Pollock; B H Minshew; E Casillas; F D Schoenknecht
Journal:  Antimicrob Agents Chemother       Date:  1980-01       Impact factor: 5.191

6.  Effect of cation content of agar on the activity of gentamicin, tobramycin, and amikacin against Pseudomonas aeruginosa.

Authors:  J A Washington; R J Snyder; P C Kohner; C G Wiltse; D M Ilstrup; J T McCall
Journal:  J Infect Dis       Date:  1978-02       Impact factor: 5.226

7.  Influence of cation supplements on activity of netilmicin against Pseudomonas aeruginosa in vitro and in vivo.

Authors:  A L Barry; G H Miller; C Thornsberry; R S Hare; R N Jones; R R Lorber; R Ferraresi; C Cramer
Journal:  Antimicrob Agents Chemother       Date:  1987-10       Impact factor: 5.191
  7 in total
  9 in total

1.  Factors influencing broth microdilution antimicrobial susceptibility test results for dalbavancin, a new glycopeptide agent.

Authors:  Robert P Rennie; Laura Koeth; Ronald N Jones; Thomas R Fritsche; Cindy C Knapp; Scott B Killian; Beth P Goldstein
Journal:  J Clin Microbiol       Date:  2007-08-01       Impact factor: 5.948

2.  Sensitization of intracellular Salmonella enterica serovar Typhimurium to aminoglycosides in vitro and in vivo by a host-targeted antimicrobial agent.

Authors:  Jung-Hsin Lo; Samuel K Kulp; Ching-Shih Chen; Hao-Chieh Chiu
Journal:  Antimicrob Agents Chemother       Date:  2014-09-29       Impact factor: 5.191

3.  Revision of quality control limits for broth microdilution tests of fleroxacin and gentamicin with Pseudomonas aeruginosa ATCC 27853.

Authors:  A L Barry; S D Allen; P C Fuchs; J H Jorgensen; M A Pfaller
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1994-12       Impact factor: 3.267

4.  Comparison of Minocycline Susceptibility Testing Methods for Carbapenem-Resistant Acinetobacter baumannii.

Authors:  Peng Wang; Sarah L Bowler; Serena F Kantz; Roberta T Mettus; Yan Guo; Christi L McElheny; Yohei Doi
Journal:  J Clin Microbiol       Date:  2016-09-14       Impact factor: 5.948

5.  Influence of pulmonary surfactant on in vitro bactericidal activities of amoxicillin, ceftazidime, and tobramycin.

Authors:  A van 't Veen; J W Mouton; D Gommers; J A Kluytmans; P Dekkers; B Lachmann
Journal:  Antimicrob Agents Chemother       Date:  1995-02       Impact factor: 5.191

6.  Variability in Zinc Concentration among Mueller-Hinton Broth Brands: Impact on Antimicrobial Susceptibility Testing of Metallo-β-Lactamase-Producing Enterobacteriaceae.

Authors:  Anastasia Bilinskaya; Douglas J Buckheit; Michael Gnoinski; Tomefa E Asempa; David P Nicolau
Journal:  J Clin Microbiol       Date:  2020-11-18       Impact factor: 5.948

7.  MexXY multidrug efflux system of Pseudomonas aeruginosa.

Authors:  Yuji Morita; Junko Tomida; Yoshiaki Kawamura
Journal:  Front Microbiol       Date:  2012-11-28       Impact factor: 5.640

8.  MexAB-OprM Efflux Pump Interaction with the Peptidoglycan of Escherichia coli and Pseudomonas aeruginosa.

Authors:  Miao Ma; Margaux Lustig; Michèle Salem; Dominique Mengin-Lecreulx; Gilles Phan; Isabelle Broutin
Journal:  Int J Mol Sci       Date:  2021-05-18       Impact factor: 5.923

9.  Genetic Determinants Enabling Medium-Dependent Adaptation to Nafcillin in Methicillin-Resistant Staphylococcus aureus.

Authors:  Michael J Salazar; Henrique Machado; Nicholas A Dillon; Hannah Tsunemoto; Richard Szubin; Samira Dahesh; Joseph Pogliano; George Sakoulas; Bernhard O Palsson; Victor Nizet; Adam M Feist
Journal:  mSystems       Date:  2020-03-31       Impact factor: 6.496
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.